These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37107032)

  • 1.
    Ioannou P; Alexakis K; Maraki S; Kofteridis DP
    Antibiotics (Basel); 2023 Mar; 12(4):. PubMed ID: 37107032
    [No Abstract]   [Full Text] [Related]  

  • 2. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015-2020: COVID-19 Aftermath.
    Chamieh A; Zgheib R; El-Sawalhi S; Yammine L; El-Hajj G; Zmerli O; Afif C; Rolain JM; Azar E
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439065
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Herrera S; Morata L; Sempere A; Verdejo M; Del Rio A; Martínez JA; Cuervo G; Hernández-Meneses M; Chumbita M; Pitart C; Puerta P; Monzó P; Lopera C; Aiello F; Mendoza S; Garcia-Vidal C; Soriano A; Bodro M
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiology in burns patients with blood stream infections: trends over time and during the course of hospitalization.
    Sousa D; Ceniceros A; Galeiras R; Pértega-Díaz S; Gutiérrez-Urbón JM; Rodríguez-Mayo M; López-Suso E; Mourelo-Fariña M; Llinares P
    Infect Dis (Lond); 2018 Apr; 50(4):289-296. PubMed ID: 29105600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and outcomes of inpatients with carbapenem-resistant
    Yuan Q; Guo L; Li B; Zhang S; Feng H; Zhang Y; Yu M; Hu H; Chen H; Yang Q; Qu T
    Front Microbiol; 2023; 14():1137811. PubMed ID: 37260693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections in the era of the COVID-19 pandemic: Changing epidemiology of antimicrobial resistance in the intensive care unit.
    Ntziora F; Giannitsioti E
    J Intensive Med; 2024 Jul; 4(3):269-280. PubMed ID: 39035613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
    Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
    Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Stream Infections in COVID-19 Patients From a Tertiary Care Center in Lebanon: Causative Pathogens and Rates of Multi-Drug Resistant Organisms.
    Nahhal SB; Zakhour J; Shmoury AH; Sawma T; Haddad SF; Abdallah T; Zahreddine NK; Tannous J; Haddad N; Rizk N; Kanj SS
    Mayo Clin Proc Innov Qual Outcomes; 2023 Dec; 7(6):556-568. PubMed ID: 38075430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-drug resistant (MDR) and extensively drug-resistant (XDR) bacteraemia rates among cancer patients in an oncology hospital in eastern India: an 11-year retrospective observational study.
    Mukherjee S; De MS; Goel G; Bhattacharyya A; Mallick I; Dabkara D; Bhaumik J; Roy MK; Majumdar PB; Chatterji S; Mukherjee S; Bhattacharya S; Chandy M
    Infect Prev Pract; 2023 Jun; 5(2):100275. PubMed ID: 36915471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-drug resistant bacteria predict mortality in bloodstream infection in a tertiary setting in Tanzania.
    Manyahi J; Kibwana U; Mgimba E; Majigo M
    PLoS One; 2020; 15(3):e0220424. PubMed ID: 32130227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR)
    Meschiari M; Orlando G; Kaleci S; Bianco V; Sarti M; Venturelli C; Mussini C
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Susceptibility Trends and Risk Factors for Antimicrobial Resistance in
    Kang JS; Moon C; Mun SJ; Lee JE; Lee SO; Lee S; Lee SH
    J Korean Med Sci; 2021 Nov; 36(43):e273. PubMed ID: 34751008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors and Outcomes of Patients with Carbapenem-Resistant
    Wei X; Li L; Li M; Liang H; He Y; Li S
    Infect Drug Resist; 2023; 16():337-346. PubMed ID: 36698726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
    Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
    Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
    Pilmis B; Alby-Laurent F; Fasola ML; Seegers V; Guery R; Guet-Revillet H; Postaire M; Toubiana J; Bille E; Lortholary O; Zahar JR
    Eur J Pediatr; 2020 Aug; 179(8):1247-1254. PubMed ID: 32080759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.